BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12904143)

  • 1. Toxicogenomics: an opportunity to optimise drug development and safety evaluation.
    Kramer JA; Kolaja KL
    Expert Opin Drug Saf; 2002 Sep; 1(3):275-86. PubMed ID: 12904143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in pharmacogenomics technologies.
    Bhasker CR; Hardiman G
    Pharmacogenomics; 2010 Apr; 11(4):481-5. PubMed ID: 20350126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicogenomics: challenges and opportunities.
    Orphanides G
    Toxicol Lett; 2003 Apr; 140-141():145-8. PubMed ID: 12676460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of investigative molecular toxicology in early stage drug development.
    Gross CJ; Kramer JA
    Expert Opin Drug Saf; 2003 Mar; 2(2):147-59. PubMed ID: 12904115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems biology in drug safety and metabolism: integration of microarray, real-time PCR and enzyme approaches.
    Yengi LG
    Pharmacogenomics; 2005 Mar; 6(2):185-92. PubMed ID: 15882137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the pharmacogenetics of cancer chemotherapy.
    Watters JW; McLeod HL
    Curr Opin Mol Ther; 2002 Dec; 4(6):565-71. PubMed ID: 12596358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates.
    Kramer JA; Sagartz JE; Morris DL
    Nat Rev Drug Discov; 2007 Aug; 6(8):636-49. PubMed ID: 17643090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicogenomics in predictive toxicology in drug development.
    Suter L; Babiss LE; Wheeldon EB
    Chem Biol; 2004 Feb; 11(2):161-71. PubMed ID: 15123278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promise of toxicogenomics.
    Waring JF; Halbert DN
    Curr Opin Mol Ther; 2002 Jun; 4(3):229-35. PubMed ID: 12139308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iconix Biosciences, Inc.
    Fielden MR; Halbert DN
    Pharmacogenomics; 2007 Apr; 8(4):401-5. PubMed ID: 17391077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicogenomics in drug development.
    Guerreiro N; Staedtler F; Grenet O; Kehren J; Chibout SD
    Toxicol Pathol; 2003; 31(5):471-9. PubMed ID: 14692614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Toxicogenomics--a new paradigm of toxicology and birth of reverse toxicology].
    Hirabayashi Y; Inoue T
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2002; (120):39-52. PubMed ID: 12638183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary roles for toxicologic pathology and mathematics in toxicogenomics, with special reference to data interpretation and oscillatory dynamics.
    Morgan KT; Pino M; Crosby LM; Wang M; Elston TC; Jayyosi Z; Bonnefoi M; Boorman G
    Toxicol Pathol; 2004; 32 Suppl 1():13-25. PubMed ID: 15209399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Informatics and multivariate analysis of toxicogenomics data.
    Salter AH; Nilsson KC
    Curr Opin Drug Discov Devel; 2003 Jan; 6(1):117-22. PubMed ID: 12613283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug evaluation, drug development and pharmacogenetics: celebrating 30 years of progress.
    Li Wan Po A
    J Clin Pharm Ther; 2005 Feb; 30(1):1-4. PubMed ID: 15658998
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxicogenomic approach for assessing toxicant-related disease.
    Waters MD; Olden K; Tennant RW
    Mutat Res; 2003 Nov; 544(2-3):415-24. PubMed ID: 14644344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of toxicogenomics.
    Hamadeh HK; Amin RP; Paules RS; Afshari CA
    Curr Issues Mol Biol; 2002 Apr; 4(2):45-56. PubMed ID: 11931569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of DNA microarrays in pharmacogenomics and toxicogenomics.
    Chin KV; Kong AN
    Pharm Res; 2002 Dec; 19(12):1773-8. PubMed ID: 12523654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicogenomics; transcript profiling and potential application to chemical allergy.
    Pennie WD; Kimber I
    Toxicol In Vitro; 2002 Jun; 16(3):319-26. PubMed ID: 12020605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of toxicogenomics in drug safety evaluation: Current status and an industry perspective.
    Vahle JL; Anderson U; Blomme EAG; Hoflack JC; Stiehl DP
    Regul Toxicol Pharmacol; 2018 Jul; 96():18-29. PubMed ID: 29679677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.